CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Avalyn Pharma Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Avalyn Pharma Inc
105 W First St
Phone: (206) 707-0340p:206 707-0340 BOSTON, MA  02127  United States Ticker: AVLNAVLN
Business Summary
Avalyn Pharma, Inc. operates within the healthcare sector. The Company specializes in developing targeted therapeutics for rare respiratory diseases, specifically idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILD). It aims to provide treatment options that reduce systemic exposure and deliver medication directly to the site of disease.
(Source: AI Generated Content – Human Reviewed & Approved)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
---Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202512/31/2025YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
2836 Biological products, except diagnostic substances
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board Heather D.Turner 53 10/1/2024 10/1/2024
President, Chief Executive Officer, Director LynBaranowski 50 10/1/2022 10/1/2022
Chief Financial Officer, Chief Business Officer DouglasCarlson 47 5/1/2024 5/1/2024
6 additional Officers and Directors records available in full report.

Business Names
Business Name
AVALYN PHAMA INC
Avalyn Pharma Pty Ltd
AVLN

General Information
Number of Employees: 51 (As of 12/31/2025)
Outstanding Shares: 41,812,047 (As of 12/31/2025)
Stock Exchange: NASD
Federal Tax Id: 452463191
Fax Number: (302) 655-5049


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, May 19, 2026